BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to H1975 cell line is 57
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay and SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1739 | 23009336 |
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.48 | 0.1739 | 28440478 |
| MCL1 | 6943 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 23418490 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 29888108 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | Western Blotting | NA | 0.48 | 0.5461 | 34475041 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR followed by SFA | NA | 0.48 | 0.5461 | 32922547 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and qRT-PCR | NA | 0.48 | 0.5461 | 29980786 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by qRT-PCR | NA | 0.48 | 0.5461 | 23009336 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.48 | 0.5461 | 28440478 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and FACs for CSC marker followed by Transcriptomics | NA | 0.48 | 0.5461 | 35229723 |
| PAX6 | 8620 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR and Western Blotting and Tumorigenicity assay | NA | 0.48 | 0.0021 | 29980786 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 29888108 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 33922104 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | Western Blotting | NA | 0.48 | 0.6448 | 34475041 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR followed by SFA | NA | 0.48 | 0.6448 | 32922547 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by qRT-PCR | NA | 0.48 | 0.6448 | 23009336 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and FACs for CSC marker followed by Transcriptomics | NA | 0.48 | 0.6448 | 35229723 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 29888108 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | Western Blotting | NA | 0.48 | 0.5695 | 34475041 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and Western Blotting | NA | 0.48 | 0.5695 | 29980786 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Osimertinib | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 30910592 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR followed by SFA | NA | 0.48 | 0.5695 | 32922547 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by qRT-PCR | NA | 0.48 | 0.5695 | 23009336 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and FACs for CSC marker followed by Transcriptomics | NA | 0.48 | 0.5695 | 35229723 |
| SOX5 | 11201 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR and Western Blotting followed by SFA and Migration Invasion assay | NA | 0.48 | 0.0011 | 29888108 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | FACs followed by SFA and RT-PCR | NA | 0.32 | 0.211 | 25678473 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | FACs followed by SFA and RT-PCR | NA | 0.32 | 0.7582 | 25678473 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR | NA | 0.32 | 0.7582 | 26447186 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.32 | 0.7582 | 28440478 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | FACs | NA | 0.32 | 0.7582 | 29958884 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Osimertinib | SFA followed by FACs | NA | 0.32 | 0.7582 | 30910592 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Osimertinib | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 30910592 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Afatinib | ALDEFLUOR assay followed by FACs | NA | 0.28 | 0.684 | 30885551 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Gefitinib | ALDEFLUOR assay followed by FACs | NA | 0.28 | 0.684 | 30885551 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Osimertinib | ALDEFLUOR assay followed by FACs | NA | 0.28 | 0.684 | 30885551 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | ALDEFLUOR assay followed by FACs and SFA | NA | 0.28 | 0.684 | 28830450 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | ALDEFLUOR assay followed by FACs and SFA | NA | 0.28 | 0.684 | 28927099 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.684 | 26447186 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.28 | 0.684 | 28440478 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | ALDEFLUOR assay followed by SFA | NA | 0.28 | 0.684 | 24607842 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by ALDEFLUOR assay | NA | 0.28 | 0.684 | 23418490 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by ALDEFLUOR assay | NA | 0.28 | 0.684 | 23418490 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and ALDEFLUOR assay | NA | 0.28 | 0.684 | 26297432 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and FACs for CSC marker followed by Transcriptomics | NA | 0.28 | 0.684 | 35229723 |
| CCND1 | 1582 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 33922104 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by Western Blotting | NA | 0.28 | 1 | 33922104 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.28 | 1 | 28440478 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by FACs | NA | 0.28 | 1 | 27577075 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | Osimertinib | SFA followed by FACs | NA | 0.28 | 1 | 30910592 |
| NOTCH1 | 7881 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0477 | 33922104 |
| USP4 | 12627 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.0021 | 32549341 |
| ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SP assay followed by SFA and RT-PCR | NA | 0.2 | 0.0604 | 28440478 |
| MYC | 7553 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.1304 | 32922547 |
| USP29 | 18563 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | RT-PCR followed by Tumorigenicity assay | NA | 0.2 | 0.0011 | 32968046 |
| ZIC2 | 12873 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | qRT-PCR followed by SFA and Tumorigenicity assay | NA | 0.2 | 0.0011 | 32922547 |
| ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA followed by FACs | NA | 0.12 | 0.0583 | 27577075 |
| SIRPG | 15757 | LTM | Non Small Cell Lung Cancer | Adenocarcinoma | H1975 | NA | SFA and FACs for CSC marker followed by Transcriptomics | NA | 0.04 | 0.0021 | 35229723 |